Palisade Bio (PALI) Cash from Operations (2010 - 2026)
Palisade Bio's (PALI) quarterly Cash from Operations came in at 3890000.0 in Q1 2026, down 66.74% year-on-year from 11695064.43 in Q1 2025, and down 23.73% on a QoQ basis from 3144000.0 in Q4 2025.
Palisade Bio (PALI) Cash from Operations (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 17 years of Cash from Operations data on file, last reported at 3890000.0 in Q1 2026.
- On a quarterly basis, Cash from Operations fell 66.74% year-over-year to 3890000.0 in Q1 2026; TTM through Mar 2026 was 12404000.0, a 9.32% decrease from a year earlier, with the FY2025 full-year figure at 10847000.0, up 11.04% from the prior year.
- Cash from Operations for Q1 2026 stood at 3890000.0, down from 3144000.0 in the prior quarter.
- Over the last five years, Cash from Operations for PALI reached as high as 1817000.0 in Q2 2025 and fell as low as 3890000.0 in Q1 2026.
- Historically, Cash from Operations has averaged 3024882.35 across 5 years, with a median of 3144000.0 in 2025.
- On a YoY basis, Cash from Operations climbed as much as 57.91% in 2022 and fell as far as 201.12% in 2022.
- Year by year, Cash from Operations stood at 3306000.0 in 2022, then rose by 16.94% to 2746000.0 in 2023, then gained by 13.29% to 2381000.0 in 2024, then tumbled by 32.05% to 3144000.0 in 2025, then fell by 23.73% to 3890000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 3890000.0 in Q1 2026, 3144000.0 in Q4 2025, and 3553000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - | -3.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.89 Mn |
| Mar 31, 2026 | -3.89 Mn |
| Dec 31, 2025 | -3.14 Mn |
| Dec 31, 2025 | -3.14 Mn |
| Sep 30, 2025 | -3.55 Mn |
| Sep 30, 2025 | -3.55 Mn |
| Jun 30, 2025 | -1.82 Mn |
| Jun 30, 2025 | -1.82 Mn |
| Mar 31, 2025 | -2.33 Mn |
| Mar 31, 2025 | -2.33 Mn |
| Dec 31, 2024 | -2.38 Mn |
| Dec 31, 2024 | -2.38 Mn |
| Sep 30, 2024 | -3.13 Mn |
| Sep 30, 2024 | -3.13 Mn |
| Jun 30, 2024 | -3.50 Mn |
| Jun 30, 2024 | -3.50 Mn |
| Mar 31, 2024 | -3.18 Mn |
| Mar 31, 2024 | -3.18 Mn |
| Dec 31, 2023 | -2.75 Mn |
| Dec 31, 2023 | -2.75 Mn |